id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-3895	Kyrmanidou, Eirini; Kemanetzi, Christina; Stavros, Chatzopoulos; Trakatelli, Myrto-Georgia; Patsatsi, Aikaterini; Madia, Xenia; Ignatiadi, Dimitra; Kalloniati, Evangelia; Apalla, Zoe; Lazaridou, Elizabeth	A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp	2024	8	.pdf	application/pdf	5233	290	54	These results adhere to what has been presented in other real-world studies assessing psoriasis patients treated with Secukinumab [6,10,17].Additionally, it needs to be men- tioned that, in our study, almost half of the patients who dis- continued secukinumab (5/11, 45%) were bio- experienced with at least one biologic drug that failed in the management of the disease. Persistence, effective- ness, and real-world outcomes in psoriasis patients treated with secukinumab in Portugal.	cache/dpc-3895.pdf	txt/dpc-3895.txt